Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | adenosine A1 receptor | Starlite/ChEMBL | No references |
Homo sapiens | adenosine A3 receptor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | hypothetical protein | adenosine A1 receptor | 326 aa | 305 aa | 21.0 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | serine/threonine protein kinase | 0.0163 | 0.3713 | 1 |
Toxoplasma gondii | ATPase/histidine kinase/DNA gyrase B/HSP90 domain-containing protein | 0.0226 | 0.5455 | 1 |
Trypanosoma cruzi | mitochondrial DNA topoisomerase II, putative | 0.0226 | 0.5455 | 1 |
Trypanosoma cruzi | mitochondrial DNA topoisomerase II, putative | 0.0226 | 0.5455 | 1 |
Onchocerca volvulus | Putative DNA topoisomerase 2, mitochondrial | 0.0091 | 0.1747 | 1 |
Trypanosoma cruzi | DNA topoisomerase II, putative | 0.0063 | 0.0977 | 0.1791 |
Loa Loa (eye worm) | TOPoisomerase family member | 0.0091 | 0.1747 | 0.4705 |
Echinococcus multilocularis | DNA topoisomerase 2 alpha | 0.0091 | 0.1747 | 1 |
Loa Loa (eye worm) | CAMK/CAMKL/CHK1 protein kinase | 0.0163 | 0.3713 | 1 |
Brugia malayi | Probable DNA topoisomerase II | 0.0091 | 0.1747 | 0.4705 |
Entamoeba histolytica | DNA topoisomerase II, putative | 0.0091 | 0.1747 | 1 |
Schistosoma mansoni | DNA topoisomerase II | 0.0091 | 0.1747 | 0.4705 |
Leishmania major | mitochondrial DNA topoisomerase II | 0.0226 | 0.5455 | 1 |
Schistosoma mansoni | lipoxygenase | 0.0063 | 0.097 | 0.2612 |
Trypanosoma brucei | DNA topoisomerase ii | 0.0226 | 0.5455 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0063 | 0.0977 | 0.2631 |
Toxoplasma gondii | DNA topoisomerase 2, putative | 0.0091 | 0.1747 | 0.3202 |
Trypanosoma brucei | DNA topoisomerase II beta, putative | 0.0063 | 0.0977 | 0.1791 |
Brugia malayi | DNA gyrase/topoisomerase IV, A subunit family protein | 0.0091 | 0.1747 | 0.4705 |
Brugia malayi | DNA topoisomerase II, alpha isozyme | 0.0091 | 0.1747 | 0.4705 |
Trypanosoma cruzi | DNA topoisomerase II, putative | 0.0063 | 0.0977 | 0.1791 |
Chlamydia trachomatis | DNA gyrase subunit B | 0.0257 | 0.6292 | 0.6292 |
Trypanosoma brucei | DNA topoisomerase II alpha, putative | 0.0063 | 0.0977 | 0.1791 |
Onchocerca volvulus | DNA topoisomerase 2 homolog | 0.0091 | 0.1747 | 1 |
Echinococcus granulosus | DNA topoisomerase 2 alpha | 0.0091 | 0.1747 | 1 |
Leishmania major | DNA topoisomerase ii | 0.0063 | 0.0977 | 0.1791 |
Mycobacterium leprae | Probable DNA gyrase (subunit B) GyrB (DNA topoisomerase (ATP-hydrolysing)) (DNA topoisomerase II) (Type II DNA topoisomerase) | 0.0135 | 0.2938 | 1 |
Plasmodium falciparum | DNA topoisomerase 2 | 0.0091 | 0.1747 | 0.1747 |
Giardia lamblia | DNA topoisomerase II | 0.0079 | 0.1409 | 1 |
Onchocerca volvulus | DNA topoisomerase 2 homolog | 0.0091 | 0.1747 | 1 |
Echinococcus multilocularis | arachidonate 5 lipoxygenase | 0.0063 | 0.097 | 0.5552 |
Plasmodium vivax | DNA topoisomerase II, putative | 0.0091 | 0.1747 | 0.1747 |
Brugia malayi | Protein kinase domain containing protein | 0.0163 | 0.3713 | 1 |
Echinococcus granulosus | arachidonate 5 lipoxygenase | 0.0063 | 0.097 | 0.5552 |
Loa Loa (eye worm) | hypothetical protein | 0.0063 | 0.0977 | 0.2631 |
Trichomonas vaginalis | DNA topoisomerase II, putative | 0.0091 | 0.1747 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Efficacy (functional) | = 12 % | Intrinsic efficacy at Homo sapiens (human) adenosine A1 receptor expressed in CHO cells assessed as increase in intracellular calcium level by FLIPR assay relative to NECA | ChEMBL. | No reference |
Ki (functional) | > 4 | Agonist activity at Homo sapiens (human) adenosine A2a receptor expressed in CHO cells | ChEMBL. | No reference |
Ki (binding) | = 5.5 | Agonist activity at Homo sapiens (human) adenosine A3 receptor expressed in CHO cells | ChEMBL. | No reference |
Ki (binding) | = 6.6 | Agonist activity at Homo sapiens (human) adenosine A1 receptor expressed in CHO cells | ChEMBL. | No reference |
pKi (binding) | Agonist activity at Homo sapiens (human) adenosine A2b receptor expressed in CHO cells | ChEMBL. | No reference | |
Ratio (binding) | = 12 | Agonist activity at Homo sapiens (human) adenosine A1 receptor expressed in CHO cells relative to NECA | ChEMBL. | No reference |
Ratio (binding) | > 348 | Agonist activity at Homo sapiens (human) adenosine A2b receptor expressed in CHO cells relative to NECA | ChEMBL. | No reference |
Ratio (binding) | > 364 | Agonist activity at Homo sapiens (human) adenosine A3 receptor expressed in CHO cells relative to NECA | ChEMBL. | No reference |
Ratio (binding) | = 725 | Agonist activity at Homo sapiens (human) adenosine A2a receptor expressed in CHO cells relative to NECA | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.